Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial

@article{Mansouri2015EvaluationOT,
  title={Evaluation of the efficacy of cysteamine 5\% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial},
  author={P. Mansouri and S. Farshi and Z. Hashemi and B. Kasraee},
  journal={British Journal of Dermatology},
  year={2015},
  volume={173}
}
Melasma is a difficult‐to‐treat hyperpigmentary disorder. While cysteamine is a known potent depigmenting agent, its efficacy in treating melasma has not been tested. 
Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double‐blinded trial
TLDR
This study aims to determine the efficacy of cysteamine cream compared to hydroquinone cream in the treatment of melasma. Expand
Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman’s formula in subjects with epidermal melasma: A randomized, double‐blind clinical trial study
  • Maryam Karrabi, J. David, M. Sahebkar
  • Medicine
  • Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging
  • 2020
TLDR
This study was aimed at the evaluation of the effectiveness of Modified Kligman’s formula (MKF) in comparison with cysteamine 5% cream on the severity of epidermal melasma. Expand
A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women
TLDR
To assess the efficacy and safety of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women, a large number of women were enrolled in a double-blind, placebo-controlled study. Expand
A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids)
TLDR
Postinflammatory hyperpigmentation (PIH) occurs as a result of different inflammatory dermatoses and exogenous factors in individuals with darker skin types and there are concerns about irritation leading to worsening of their underlying inflammatory skin condition or worsening of PIH. Expand
Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years
TLDR
Melasma is an acquired disorder of facial pigmentation which is a treatment challenge and needs to be treated with a variety of medications. Expand
Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula
TLDR
A 44‐year‐old patient with melasma resistant to Kligman's formula (Pigmanorm cream), who was successfully treated with topical cysteamine as a new depigmenting agent, is reported. Expand
Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study
TLDR
Cysteamine cream showed significant efficacy in decreasing melanin content of the lesions, as established by Dermacatch® as a new measuring method. Expand
New oral and topical approaches for the treatment of melasma
TLDR
New and emerging oral and topical treatments for melasma are reviewed, including a multimodality approach incorporating photoprotection agents, topical and oral skin lighteners, and resurfacing procedures. Expand
Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study
TLDR
It is suggested that none of the cysteamine and TA mesotherapy treatments measured by both mMASI and Dermacatch® methods have substantial advantages over the other; however, complications are less in the Cysteamine 5% cream group than theTA mesotherapy group. Expand
A triple-blind, randomized trial of a traditional compound as compared to 4% hydroquinone in melasma
TLDR
The results showed that the herbal combination product (C. arietinum L. and C. melo seed) can be acceptable for patients with melasma and it can be an appropriate substitute for hydroquinone. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 37 REFERENCES
Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma
  • S. Farshi
  • Chemistry, Medicine
  • Journal of cosmetic dermatology
  • 2011
TLDR
This study highlights the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals, not necessarily belonging to the same breeds. Expand
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0·01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma
TLDR
This study highlights the need to understand more fully the rationale behind the continued use of laser therapy to treat hypermelanosis in patients with previously undiagnosed disease. Expand
A double‐blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma
TLDR
Background  Melasma is an acquired treatment‐resistant hyperpigmentation of the skin that is difficult to treat and may cause itching, redness, and rashes. Expand
Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma
TLDR
Glycolic acid has been added to hydroquinone formulations in the past to enhance their depigmentation effects, but may cause irritation, leading to postinflammatory hyperpigmentation. Expand
Guidelines for clinical trials in melasma
TLDR
The Pigmentary Disorders Academy has examined the issues relating to clinical trials on melasma, and proposed recommendations on how they should be conducted, including correct diagnosis of the condition, evaluation of efficacy and safety outcome, and overall clinical trial design. Expand
Guidelines for clinical trials in melasma. Pigmentation Disorders Academy.
TLDR
The Pigmentary Disorders Academy has examined the issues relating to clinical trials on melasma, and has proposed recommendations on how they should be conducted, covering all aspects including correct diagnosis of the condition, evaluation of efficacy and safety outcome, and overall clinical trial design. Expand
The treatment of melasma: a review of clinical trials.
TLDR
Combination therapies such as hydroquinone, tretinoin, and corticosteroids have been used in the treatment of melasma, and are thought to increase efficacy as compared with monotherapy, but their efficacy, safety, or trial design indicates that the interventions would need further study before they could be recommended. Expand
Treatment of Melasma with Topical Agents, Peels and Lasers: An Evidence-Based Review
TLDR
An evidence-based review of interventions available for the treatment of melasma found topical depigmenting agents were found to be the most effective in treating moderate-to-severe melasma, with combination therapies, such as triple-combination therapy, yielding the best results. Expand
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial.
TLDR
This controlled study demonstrates that topical 0.1% tretinoin lightens melasma in black patients, with only mild side effects. Expand
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
TLDR
Investigator and participant evaluations revealed that most participants showed improvement (excellent improvement, much improved, improved) by week 12 with alternating sequential treatment with TC cream and GA peels was well-tolerated. Expand
...
1
2
3
4
...